Recent Company News

• 11:38 PM ET Apr 27, 2025
  

  StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning

• 07:22 PM ET Apr 27, 2025
  

  Sinopharm Group reports Q1 net income attributable CNY1.46B, +3% vs year-ago CNY1.42B (HK$17.42, 0.00)

• 04:38 AM ET Apr 25, 2025
  

  Sinopharm Group releases sustainability report (HK$17.42, 0.00)

• 10:02 PM ET Apr 08, 2025
  

  Follow-up: US President Donald Trump says the US will unveil "major" tariff on imports of pharmaceutical goods - NBC News

• 12:32 AM ET Mar 24, 2025
  

  StreetAccount Metrics Recap - Sinopharm Group FY Earnings (HK$18.74, -0.64)

• 06:21 PM ET Mar 23, 2025
  

  Sinopharm Group reports FY net income attributable CNY7.05B vs StreetAccount CNY8.18B (HK$19.38, 0.00)

• 03:50 AM ET Mar 18, 2025
  

  Sinopharm Group initiated buy at Citic Securities (HK$19.74, +0.08)

• 11:14 AM ET Mar 16, 2025
  

  StreetAccount Consensus Metrics Preview - Sinopharm Group FY Earnings (HK$19.50, 0.00)

• 08:36 AM ET Jan 22, 2025
  

  Sinopharm Group downgraded to outperform from buy at Daiwa (HK$20.30, 0.00)

• 01:57 AM ET Dec 12, 2024
  

  Sinopharm Group upgraded to buy from fully valued at DBS Group (timing uncertain) (HK$21.55, +0.35)